June 22, 201700:15:59

Bioengineered Organ Implants Poised to Change Treatment Paradigms in Esophageal Cancer

Jim McGorry, CEO and Saverio LaFrancesca, President and Chief Medical Officer talk about how Biostage is using Cell Therapy to improve the standard of care in adult and pediatric esophageal disease.

No transcript available.